Morphosys Ag Adr Stock Fundamentals

MorphoSys AG ADR fundamentals help investors to digest information that contributes to MorphoSys' financial success or failures. It also enables traders to predict the movement of MorphoSys Stock. The fundamental analysis module provides a way to measure MorphoSys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MorphoSys stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MorphoSys AG ADR Company Return On Asset Analysis

MorphoSys' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current MorphoSys Return On Asset

    
  -0.14  
Most of MorphoSys' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MorphoSys AG ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, MorphoSys AG ADR has a Return On Asset of -0.1384. This is 98.42% lower than that of the Biotechnology sector and 99.41% lower than that of the Health Care industry. The return on asset for all United States stocks is 1.14% lower than that of the firm.

MorphoSys AG ADR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MorphoSys's current stock value. Our valuation model uses many indicators to compare MorphoSys value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MorphoSys competition to find correlations between indicators driving MorphoSys's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15ACLXIMCRPCVXDICEPMVPTHRXMOR -0.20-0.15-0.10-0.050 -2.0-1.5-1.0-0.50
MorphoSys AG ADR is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value MorphoSys by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MorphoSys Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MorphoSys' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics of similar companies.
100%
MorphoSys is currently under evaluation in return on asset category among its peers.

MorphoSys Fundamentals

Pair Trading with MorphoSys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MorphoSys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MorphoSys will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in MorphoSys Stock

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk


 

Trending Assets

PCVX
Vaxcyte
84.00  0.16  0.19 
CGEM
Cullinan Oncology LLC
9.53  -0.06  -0.63 
IMCR
Immunocore Holdings
29.60  -0.14  -0.47 
DICE
Dice Molecules Holdings
0.00  0.00  0.00